Consequently, circIGF1R overexpression diminished these pathological effects within HF-associated HCFs by attenuating glucose import into cardiac fibroblasts, thereby attributing a therapeutic potential of circIGF1R in HF therapy by alleviating cardiac fibrosis via AZGP1. This evidence concerns the gene AZGP1 and hydrops fetalis.